Senior Director, Direct to Patient Team Lead
![]() | |
![]() United States, Massachusetts, Cambridge | |
![]() 45 Sidney Street (Show on map) | |
![]() | |
How will your role help us transform hope into reality? The Senior Director, Direct-to-Patient (DTP) Team Lead will be responsible for further establishing and maintaining a leadership position for Blueprint Medicines, a Sanofi Company, among the patient and caregiver community living with systemic mastocytosis (SM). Your strategic vision will ensure we have an wholistic patient and caregiver engagement strategies, including groundbreaking patient marketing strategies and initiatives for SM and AYVAKIT (avapritinib), a potential multi-billion opportunity. Working collaboratively with cross-functional partners, you will represent the Voice of the Patient and be the driving force behind patient engagement strategies that not only speak to patients but also reinforces our Patient First mindset. AYVAKIT's ongoing launch into Indolent Systemic Mastocytosis (ISM), provides a unique opportunity to continue to build a new market and reach a patient community that had no therapeutic option until now that treated the underlying driver of disease. While ISM is a rare disease, it is extremely underdiagnosed with 9 years average time to diagnosis after seeing several types of medical specialists. You will lead the Patient Marketing team, which is collectively responsible for creating and implementing strategies across disease awareness and product promotion to support personal and non-personal/digital promotion for patient audiences. Reporting to the Vice President, Commercial Strategy & Marketing, you will be a leader in both the marketing team and broader patient connect team across the organization. Working closely with cross-functional partners: Patient Advocacy, PR/Corp Communications, Regional Marketing, Commercial Operations, and US Market Access/Patient Services is crucial to brand success. Your collaborative efforts will ensure a cohesive and patient-centric approach across all patient touchpoints. What will you do?
What minimum qualifications do we require?
What additional qualifications will make you a stronger candidate?
Why Blueprint? At Blueprint Medicines, we achieve impactful results because of our global crew of compassionate innovators - the Blue Crew. Through authentic relationships and our collective entrepreneurial spirit and action, we are each empowered to take ownership and execute with strategic prioritization. We put trust in our people to break through norms and conventions using their individual strengths and insights, which drives our success. This is the place where the extraordinary becomes reality, and you could be part of it. Patients are waiting. Are you ready to make the leap? Equity, Diversity, Inclusion and Affirmative Action At Blueprint Medicines, wefoster an environment of fair treatment and full participationforall of our employees as we navigate complex challenges in pursuing our mission to improve the lives of patients. We celebrate our unique differences and varied career and life experiences so that we can sustain our diverse culture and ensure everyone feels accepted. We arecommitted to non-discrimination, equal employment opportunity, as well as an inclusive recruitment process. We consider all qualified applicants based on merit and without regard to race, color, sex, gender identity, sexual orientation, age, religion, national origin, ancestry, ethnicity, disability, veteran status, genetic information, or any other characteristic protected under applicable federal or state law. We will make reasonable accommodations, absent undue hardship, for qualified individuals with known disabilities. If you are an individual with a disability in need of an accommodation with the application or recruiting process, please reach out to TotalRewards@blueprintmedicines.com. We are also an E-Verify Employer. For more information, please see ourEEOPolicy Statement, theE-Verify Participation Poster, theRight to Work Poster, and theEEOKnow Your Rights Poster. Blueprint Medicines, a Sanofi company, is a global biopharmaceutical company that invents life-changing medicines. We seek to improve and extend patients' lives by solving important medical problems, with a focus on allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a track record of success with two approved medicines, including AYVAKIT/AYVAKYT (avapritinib) which we are bringing to patients with SM in theU.S.andEurope. Leveraging our established research, development, and commercial capability and infrastructure, we aim to significantly scale our impact by advancing a broad pipeline of programs ranging from early science to advanced clinical trials in mast cell diseases and solid tumors. For more information, visitwww.BlueprintMedicines.comand follow us onX(formerly Twitter; @BlueprintMeds) andLinkedIn. #LI-Hybrid #LI-AQ1 |